Vardhman Drugs Private Limited, a active private limited company, was established on 31 May 1996 in Meerut, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85110UP1996PTC020052. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.20 M.
It upholds a compliant status. Employing 32 professional, Its leadership includes Manu Jain (Director), Arun Kumar Jain (Director), Abha Jain (Director). Past directors included Kunal Jain. It holds ₹10.10 Cr open charges and ₹6.51 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 101/1B Mokhampur Delhi Road Meerut Up, Meerut, Uttar Pradesh, 250002.
U85110UP1996PTC020052
020052
31 May 1996
₹1.50 M
₹1.20 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Vardhman Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manu Jain | Director | 31 May 1996 | Current |
| Arun Kumar Jain | Director | 31 May 1996 | Current |
| Abha Jain | Director | 31 May 1996 | Current |
| Surabhi Jain | Director | 20 May 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vardhman Drugs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.24% increase. The company also saw a slight improvement in profitability, with a 6.42% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Vardhman Drugs had a public holding of 5.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹101,000,000.00
₹65,100,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Nov 2021 | Axis Bank Limited | ₹6.00 Cr | Open |
| 23 Feb 2018 | Others | ₹4.10 Cr | Open |
| 29 Aug 2018 | Others | ₹8.00 M | Satisfied |
| 26 Nov 2015 | Rbl Bank Limited | ₹3.00 Cr | Satisfied |
| 20 Aug 2015 | Hdfc Bank Limited | ₹8.00 M | Satisfied |
Explore comprehensive loan charge details -
Vardhman Drugs has a workforce of 32 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Vardhman Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vardhman Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Vardhman Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Vardhman Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
A charge with Axis Bank Limited amounted to Rs. 60.00 M with Charge ID 100516293 was registered on 10 Nov 2021. was recorded as a recent event.
The activity A charge registered on 29 Aug 2018 via Charge ID 100212373 with Others was fully satisfied on 24 Sep 2021. was completed.
The activity A charge registered on 20 Aug 2015 via Charge ID 10591934 with Hdfc Bank Limited was fully satisfied on 06 Dec 2018. was completed.
The activity A charge with Others amounted to Rs. 8.00 M with Charge ID 100212373 was registered on 29 Aug 2018. was completed.
The CIN of Vardhman Drugs Private Limited is U85110UP1996PTC020052.
Vardhman Drugs Private Limited is headquartered at 101/1B Mokhampur Delhi Road Meerut Up, Meerut, Uttar Pradesh, 250002.
Vardhman Drugs Private Limited was incorporated on 31 May 1996.
The current directors of Vardhman Drugs Private Limited are
The primary industry of Vardhman Drugs Private Limited is Trade.
Vardhman Drugs Private Limited is unlisted.
The authorized capital of Vardhman Drugs Private Limited is ₹1.50 M, and the paid-up capital is ₹1.20 M.
The compliance status of Vardhman Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX